SCHEMBL2551943

SCHEMBL2551943

CC(C)N1CCC(OC2CCC(Oc3cnc(Br)cn3)CC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.46
GPR119 Q8TDV5 18/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14634616 0.85 GPR119 (0.45) GPR119
SCHEMBL14634615 0.85 GPR119 (0.45) GPR119
SCHEMBL20147451 0.83 HRH3 (0.52) HRH3GPR119
SCHEMBL2555295 0.81 HRH3 (0.50) HRH3GPR119
SCHEMBL14634789 0.80 GPR119 (0.72) GPR119
SCHEMBL14634788 0.80 GPR119 (0.72) GPR119
SCHEMBL22663355 0.80 PDGFRB (0.36) GPR119
SCHEMBL15648405 0.79 TDO2 (0.42) HRH3GPR119
SCHEMBL2553243 0.78 GPR119 (0.50) GPR119
SCHEMBL2553246 0.78 GPR119 (0.50) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2556056-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2013-02-13 EP disclosed
WO-2011127051-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2011-10-13 WO disclosed